PE20050201A1 - Pirazolopirimidinas sustituidas con 6-ciclilmetilo y 6-alquilmetilo - Google Patents

Pirazolopirimidinas sustituidas con 6-ciclilmetilo y 6-alquilmetilo

Info

Publication number
PE20050201A1
PE20050201A1 PE2004000472A PE2004000472A PE20050201A1 PE 20050201 A1 PE20050201 A1 PE 20050201A1 PE 2004000472 A PE2004000472 A PE 2004000472A PE 2004000472 A PE2004000472 A PE 2004000472A PE 20050201 A1 PE20050201 A1 PE 20050201A1
Authority
PE
Peru
Prior art keywords
pyrazole
methylphenyl
alkyl
cyclylmethyl
alkylmethyl
Prior art date
Application number
PE2004000472A
Other languages
English (en)
Spanish (es)
Inventor
Martin Hendrix
Lars Barfacker
Frank-Thorsten Hafner
Dagmar Schaub
Der Staay Franz-Josef Van
Kampen Marja Van
Adrian Tersteegen
Heike Heckroth
Christina Erb
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of PE20050201A1 publication Critical patent/PE20050201A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
PE2004000472A 2003-05-09 2004-05-07 Pirazolopirimidinas sustituidas con 6-ciclilmetilo y 6-alquilmetilo PE20050201A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10320784 2003-05-09
DE10336183 2003-08-07
DE102004004142A DE102004004142A1 (de) 2003-05-09 2004-01-28 6-Cyclylmethyl- und 6-Alkylmethyl-substituierte Pyrazolopyrimidine

Publications (1)

Publication Number Publication Date
PE20050201A1 true PE20050201A1 (es) 2005-05-27

Family

ID=33420016

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2004000472A PE20050201A1 (es) 2003-05-09 2004-05-07 Pirazolopirimidinas sustituidas con 6-ciclilmetilo y 6-alquilmetilo

Country Status (9)

Country Link
EP (1) EP2298773B1 (https=)
JP (1) JP5277303B2 (https=)
CL (1) CL2004000978A1 (https=)
DE (1) DE102004004142A1 (https=)
MY (1) MY148252A (https=)
NZ (1) NZ543812A (https=)
PE (1) PE20050201A1 (https=)
RU (1) RU2383546C2 (https=)
TW (1) TWI350836B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201439091A (zh) * 2013-04-05 2014-10-16 Eisai R&D Man Co Ltd 吡啶基吡唑并喹啉化合物
WO2018221550A1 (ja) 2017-06-01 2018-12-06 エーザイ・アール・アンド・ディー・マネジメント株式会社 ピラゾロキノリン誘導体とメマンチンの併用による認知症治療剤
RU2019135834A (ru) 2017-06-01 2021-07-13 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Терапевтическое средство для лечения деменции, представляющее собой комбинацию производного пиразолохинолина и донепезила
BR112019023552A2 (pt) 2017-06-01 2020-06-02 Eisai R&D Management Co., Ltd. Agente terapêutico para a demência com corpos de lewy contendo derivado de pirazoloquinolina
KR20200010211A (ko) 2017-06-01 2020-01-30 에자이 알앤드디 매니지먼트 가부시키가이샤 Pde9 저해제를 포함하는 약제학적 조성물

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1161281B (de) 1960-05-11 1964-01-16 Ciba Aktiengesellschaft, Basel (Schweiz) Verfahren zur Herstellung von 1-Alkyl-6-aralkyl-pyrazoloÄ3,4-dÜ-pyrimidinen.
DE1147234B (de) 1960-05-11 1963-04-18 Ciba Geigy Verfahren zur Herstellung von 1-Isopropyl-4-hydroxy-6-benzyl-pyrazolo[3, 4-d]pyrimidin
CH396926A (de) 1960-05-11 1965-08-15 Ciba Geigy Verfahren zur Herstellung neuer Pyrazolopyrimidine
CH396927A (de) 1960-05-11 1965-08-15 Ciba Geigy Verfahren zur Herstellung neuer Pyrazolopyrimidine
DE1149013B (de) 1960-05-11 1963-05-22 Ciba Geigy Verfahren zur Herstellung von 4-Oxo-4, 5-dihydro-pyrazolo-[3, 4-d]Pyrimidinen
CH396925A (de) 1960-05-11 1965-08-15 Ciba Geigy Verfahren zur Herstellung neuer Pyrazolopyrimidine
CH396924A (de) 1960-05-11 1965-08-15 Ciba Geigy Verfahren zur Herstellung von 4-Mercapto-pyrazolo(3,4-d)pyrimidinen
US3732225A (en) 1970-07-23 1973-05-08 Squibb & Sons Inc Pyrazolo(3,4-d)pyrimidine derivatives
US3847908A (en) 1973-03-05 1974-11-12 Squibb & Sons Inc 6-styrylpyrazolo(3,4-d)pyrimidinones and pyrimidines
ES2077591T3 (es) 1989-01-26 1995-12-01 Bayer Ag Derivados de acido (met)acrilico opticamente activos, su fabricacion, su polimerizacion para dar polimeros opticamente activos y su uso.
RU2104216C1 (ru) * 1994-01-10 1998-02-10 Акционерное общество открытого типа "Таганрогский авиационный научно-технический комплекс им.Г.М.Бериева" Замок
DE19709877A1 (de) 1997-03-11 1998-09-17 Bayer Ag 1,5-Dihydro-pyrazolo[3,4-d]-pyrimidinon-derivate
WO2002009713A2 (de) * 2000-08-01 2002-02-07 Bayer Aktiengesellschaft Selektive pde 2-inhibitoren als arzneimittel zur verbesserung der wahrnehmung
HN2002000317A (es) * 2001-11-02 2003-05-21 Pfizer Inhibidores de pde9 para tratamiento de trastornos cardiovasculares
EP1444009A1 (en) * 2001-11-02 2004-08-11 Pfizer Products Inc. Treatment of insulin resistance syndrome and type 2 diabetes with pde9 inhibitors
DE10219435A1 (de) * 2002-05-02 2003-11-13 Bayer Cropscience Ag Substituierte Pyrazolo-pyrimidin-4-one

Also Published As

Publication number Publication date
JP2012036221A (ja) 2012-02-23
JP5277303B2 (ja) 2013-08-28
RU2383546C2 (ru) 2010-03-10
EP2298773B1 (de) 2013-06-19
CL2004000978A1 (es) 2005-03-18
MY148252A (en) 2013-03-29
TW200508237A (en) 2005-03-01
NZ543812A (en) 2010-06-25
TWI350836B (en) 2011-10-21
DE102004004142A1 (de) 2004-11-25
EP2298773A1 (de) 2011-03-23
RU2005138339A (ru) 2006-08-10

Similar Documents

Publication Publication Date Title
PE20060316A1 (es) Derivados de prolina como inhibidores de dipeptidil peptidasa-iv
PE20001419A1 (es) COMPLEJO DEL INHIBIDOR DE RAS-FARNESILTRANSFERASA Y SULFOBUTILETER-7-ß-CICLODEXTRINA O 2-HIDROXIPROPIL-ß-CICLODEXTRINA Y METODO
PE20080139A1 (es) Compuestos de pirrolotriazina anilina como inhibidores de cinasa
PE20060197A1 (es) Heterociclos biciclicos como inhibidores de cinasa
ATE273961T1 (de) Verfahren zur herstellung von 4- trifluormethylsulfinylpyrazolderivat
ECSP034707A (es) Derivados de urea como antagonistas de alfa integrado
AR061492A2 (es) Procedimiento para la preparacion de compuestos intermediarios para la preparacion de 5-amino-1-aril-3-ciano pirazoles
PE20050489A1 (es) Antagonistas de receptores de acetilcolina muscarinicos
PE20020470A1 (es) Derivados de pirazol como inhibidores de las enzimas proteina quinasas
PE20120121A1 (es) Derivados de imidazopirazina como inhibidores de syk
DE60330800D1 (de) Verfahren zur herstellung von pyrrolotriazinverbindungen, die sich als kinaseinhibitoren eignen
PE20040914A1 (es) Derivados de pirrolopirimidina como inhibidores de tirosina quinasas
PE20040934A1 (es) Derivados de pirimidina como inhibidores selectivos de tirosina quinasas
NO20072382L (no) (S)-(-)-1-(4-Fluorisokinolin-5-yl)-sulfonyl-2-metyl-1,4-homopiperazinhydroklorid dihydrat
Brown Fused Pyrimidines, Volume 24, Part 3: Pteridines
AR104918A1 (es) Procesos e intermediarios para la preparación de {1-(etilsulfonil)-3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il]azetidin-3-il}acetonitrilo
ES2031569T3 (es) Derivados de acidos quinolinocarboxilicos.
PE20050201A1 (es) Pirazolopirimidinas sustituidas con 6-ciclilmetilo y 6-alquilmetilo
PE20051171A1 (es) Inhibidores de proteina quinasas con estructura de 3-quinolincarbonitrilo
ES8505997A1 (es) Un procedimiento para la preparacion de dihidropiridinas
DE60205769D1 (de) Verfahren zur herstellung von amphetaminen aus phenylpropanolaminen
ATE531702T1 (de) Verfahren zur herstellung von epoxytriazolderivat und zwischenprodukten dafür
KR840008155A (ko) 트리아조로[4,3,-c] 피리미딘과 트리아조로[1,5-c]피리미딘의 제조방법
PA8563601A1 (es) Acidos-3-(imidazolil)-2- alcoxipropanoicos
ECSP045309A (es) Derivados de fenil amidas con silicio útiles como microbiocidas

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed